Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million Post author:Sam Post published:February 28, 2018 Post category:BioPharma Finch Therapeutics closed on an oversubscribed Series B financing worth $36 million. Source: BioSpace You Might Also Like GlaxoSmithKline Poaches AstraZeneca PLC Exec to Replace Exiting Pharma Head January 18, 2017 Cellect Is Moving To Trade Exclusively On The June 8, 2017 VANC Pharmaceuticals Appoints To Board Of Directors August 15, 2017
